Surgical Innovations Group PLC - Leeds, England-based surgical & medical instrument manufacturer - Posts revenue of £11.3 million for 2022, up 24% from £9.1 million in 2021. Pretax loss narrows to £57,000 from £585,000. Swings to an operating profit of £41,000 from a loss of £455,000 a year earlier. Adjusted earnings before interest, tax, depreciation and amortisation is £700,000, up from £500,000 in 2021. Surgical notes strong sales in UK, Japan and key European markets. Looking ahead, says revenue in the current year to date for SI brand and Distribution sales are 9.2% ahead of the corresponding period last year. Expects to continue to trade profitably at the level of adjusted Ebitda, supported by the continual investment in operations during 2023.

Chair Nigel Rogers says: ‘Whilst the backlog of patients requiring treatment in the UK continues to increase, standing at 7.2 million in December 2022, sales remain strong.’

Current stock price: 1.99 pence each, up 4.7% on Wednesday around midday in London

12-month change: down 9.6%

Copyright 2023 Alliance News Ltd. All Rights Reserved.